17 alpha-hydroxyprogesterone caproate and Stillbirth

17 alpha-hydroxyprogesterone caproate has been researched along with Stillbirth in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Das, AF; Gudeman, J; Saade, GR; Sibai, B	1
Chomba, E; Cole, SR; Freeman, BL; Goldenberg, RL; Mbewe, FM; Mofenson, LM; Mulenga, HB; Price, JT; Rouse, DJ; Stringer, JSA; Vwalika, B; Winston, J	1
O'Brien, JM	1
Brent, RL; Calda, P; Christian, MS	1

Reviews

3 review(s) available for 17 alpha-hydroxyprogesterone caproate and Stillbirth

Article	Year
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth. Journal of perinatology : official journal of the California Perinatal Association, 2021, Volume: 41, Issue:4 Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Stillbirth; United States; United States Food and Drug Administration	2021
The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment. American journal of perinatology, 2012, Volume: 29, Issue:9 Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Animals; Blood Glucose; Clinical Trials as Topic; Female; Fetal Death; Fetal Development; Hormone Antagonists; Humans; Hydroxyprogesterones; Immunity, Innate; Pregnancy; Pregnancy, Multiple; Premature Birth; Progesterone; Progestins; Receptors, Progesterone; Stillbirth	2012
Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2007, Volume: 20, Issue:2 Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Abortion, Spontaneous; Animals; Drug Compounding; Hydroxyprogesterones; Premature Birth; Progesterone Congeners; Progestins; Stillbirth	2007

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Stillbirth

Article	Year
Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial. BMC pregnancy and childbirth, 2019, Feb-27, Volume: 19, Issue:1 Topics: 17 alpha-Hydroxyprogesterone Caproate; Anti-HIV Agents; Clinical Trials, Phase III as Topic; Developing Countries; Female; Gestational Age; HIV Infections; Humans; Injections, Intramuscular; Live Birth; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Progestins; Randomized Controlled Trials as Topic; Stillbirth; Zambia	2019

Article

Year

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.

BMC pregnancy and childbirth, 2019, Feb-27, Volume: 19, Issue:1

Topics: 17 alpha-Hydroxyprogesterone Caproate; Anti-HIV Agents; Clinical Trials, Phase III as Topic; Developing Countries; Female; Gestational Age; HIV Infections; Humans; Injections, Intramuscular; Live Birth; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Progestins; Randomized Controlled Trials as Topic; Stillbirth; Zambia

2019